Miltenyi Biotec Inc. Sustainability Profile
Miltenyi Biotec Inc., a leading player in the life sciences industry, is headquartered in the United States and operates extensively across Europe and Asia. Founded in 1989, the company has established itself as a pioneer in the development of innovative tools and technologies for biomedical research and cellular therapy. Miltenyi Biotec is renowned for its core products, including cell separation systems, flow cytometry solutions, and gene editing technologies, which are distinguished by their precision and reliability. The company’s commitment to advancing scientific research has positioned it as a trusted partner for researchers and clinicians worldwide. With a strong market presence and a reputation for excellence, Miltenyi Biotec continues to drive advancements in the fields of immunology, oncology, and regenerative medicine, contributing significantly to the evolution of modern healthcare solutions.
DitchCarbon Score
How does Miltenyi Biotec Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Miltenyi Biotec Inc.'s score of 28 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Miltenyi Biotec Inc.'s reported carbon emissions
Miltenyi Biotec Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of reported emissions figures. The company is a current subsidiary of Miltenyi Biotec GmbH, which may influence its climate commitments and initiatives. While there are no documented reduction targets or climate pledges from Miltenyi Biotec Inc. itself, it is important to note that any potential commitments or targets may be inherited from its parent company, Miltenyi Biotec GmbH. However, specific details regarding these initiatives or emissions data have not been provided. As a part of the broader industry context, Miltenyi Biotec Inc. is expected to align with standard climate practices, potentially engaging in initiatives such as the Science Based Targets initiative (SBTi) or other sustainability frameworks, although no specific commitments have been disclosed at this time. In summary, while Miltenyi Biotec Inc. does not currently report emissions data or reduction targets, its affiliation with Miltenyi Biotec GmbH may play a role in shaping its future climate strategies.
How Carbon Intensive is Miltenyi Biotec Inc.'s Industry?
How Carbon Intensive is Miltenyi Biotec Inc.'s Location?
Miltenyi Biotec Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Miltenyi Biotec Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
